On 2025-05-07, Revolution Medicines, Inc. (RVMD) announced earnings per share of $-1.13 for the fiscal quarter ending 2025-03-31, missing the average analyst estimate of $-1.12.
The next expected annoucement date for quarterly earnings is 2025-08-06, with an average estimated earnings per share of $-1.14 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-07 | 2025-03-31 | $-1.12 | $-1.13 |
| 2025-02-26 | 2024-12-31 | $-0.99 | $-1.12 |
| 2024-11-06 | 2024-09-30 | $-0.89 | $-0.94 |
| 2024-08-07 | 2024-06-30 | $-0.77 | $-0.81 |
| 2024-05-08 | 2024-03-31 | $-0.75 | $-0.70 |
| 2024-02-26 | 2023-12-31 | $-0.86 | $-1.14 |
| 2023-11-06 | 2023-09-30 | $-1.01 | $-0.99 |
| 2023-08-08 | 2023-06-30 | $-0.83 | $-0.92 |
| 2023-05-08 | 2023-03-31 | $-0.84 | $-0.72 |
| 2023-02-27 | 2022-12-31 | $-0.84 | $-0.63 |
| 2022-11-07 | 2022-09-30 | $-0.87 | $-0.87 |
| 2022-08-09 | 2022-06-30 | $-0.87 | $-0.82 |
| 2022-05-09 | 2022-03-31 | $-0.82 | $-0.78 |
| 2022-02-28 | 2021-12-31 | $-0.65 | $-0.71 |
| 2021-11-10 | 2021-09-30 | $-0.62 | $-0.72 |
| 2021-08-11 | 2021-06-30 | $-0.55 | $-0.60 |
| 2021-05-10 | 2021-03-31 | $-0.52 | $-0.53 |
| 2021-03-02 | 2020-12-31 | $-0.37 | $-0.52 |
| 2020-11-12 | 2020-09-30 | $-0.39 | $-0.42 |
| 2020-08-10 | 2020-06-30 | $-0.34 | $-0.46 |
| 2020-05-14 | 2020-03-31 | $-0.33 | $-0.74 |